Analyst Price Targets — BNGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2025 11:53 am | Jason McCarthy | Maxim Group | $8.00 | $3.77 | TheFly | Bionano Genomics upgraded to Buy from Hold at Maxim |
| August 28, 2024 6:51 am | Sung Ji Nam | Scotiabank | $1.00 | $0.51 | TheFly | Bionano Genomics downgraded at Scotiabank on limited capital market visibility |
| May 16, 2024 4:45 am | Mark Massaro | BTIG | $2.00 | $1.15 | StreetInsider | Bionano Genomics (BNGO) PT Lowered to $2 at BTIG |
| May 25, 2023 2:47 pm | Bionano Genomics's | EF Hutton | $175.00 | $65.00 | Benzinga | Bionano Genomics' Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway |
| December 12, 2022 8:34 am | — | BTIG | $350.00 | $219.00 | Benzinga | BTIG Assumes Bionano Genomics at Buy, Announces Price Target of $3.5 |
Latest News for BNGO
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to…
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases,…
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome Mapping (OGM). The session revealed how OGM can offer a new standard for detecting and characterizing structural variants (SVs) across cancer, including its unprecedented…
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM). Hematologic malignancies are cancers of the blood and lymph systems.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BNGO.
U.S. House Trading
No House trades found for BNGO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.